Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Suspended 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 92Genitourinary 10Thoracic 9Head & Neck 9Breast 9Endocrine 6Gynecologic 4Tumor-Agnostic 3Sarcoma 2Other solid neoplasm 2NET 1Lymphoid 1Dermatologic 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Radiofrequency Ablation × Tumor-Agnostic × Clear all
NCT04375891 2025-02-04

Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation

Baptist Health South Florida

Phase NA Active not recruiting
63 enrolled
Tumor-Agnostic

Neoplasms

NCT00382252 2022-03-09

TEPARF

Institut Bergonié

Phase NA Completed
89 enrolled 8 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT00868647 2009-09-01

Radiofrequency Ablation (RFA) Of Tumors Acquired In Childhood

Seattle Children's Hospital

Phase 2 Suspended
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡